![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
As of October 2023, Amedeo had |
Prostate Cancer |
Free Subscription
1 Anticancer Res |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Prostate Cancer is free of charge.
The Impact of Pathological Grade Group 3 on Relapse-free Survival After Salvage
Radiotherapy for Postoperative Prostate Cancer.
Anticancer Res. 2023;43:5115-5125.
PubMed
Abstract available
Focal Therapy with High-Intensity Focused Ultrasound for Prostate Cancer: Three
Year Outcomes from a Prospective Trial.
BJU Int. 2023 Oct 27. doi: 10.1111/bju.16213.
PubMed
Abstract available
CONFIRM trial Protocol: The utility of PSMA PET/CT in active surveillance for
prostate cancer.
BJU Int. 2023 Oct 30. doi: 10.1111/bju.16214.
PubMed
Abstract available
Patient-reported outcomes before treatment for localized prostate cancer: are
there differences among countries? Data from the True North Global Registry.
BMC Urol. 2023;23:178.
PubMed
Abstract available
Short-term prognosis of low-risk prostate cancer patients is favorable despite
the presence of pathological prognostic factors: a retrospective study.
BMC Urol. 2023;23:174.
PubMed
Abstract available
Prediction model of gleason score upgrading after radical prostatectomy based on
a bayesian network.
BMC Urol. 2023;23:159.
PubMed
Abstract available
Modifiable risk factors for subsequent lethal prostate cancer among men with an
initially negative prostate biopsy.
Br J Cancer. 2023 Oct 28. doi: 10.1038/s41416-023-02472.
PubMed
Abstract available
Targeting metabolic abnormality for advanced prostate cancer: The prodrug
Platin-L effectively targets the metabolic abnormality needed to make this cancer
sensitive to cisplatin.
Cancer. 2023;129:3516.
PubMed
Molecular pathogenesis, mechanism and therapy of Cav1 in prostate cancer.
Discov Oncol. 2023;14:196.
PubMed
Abstract available
Prostate MR image quality of apparent diffusion coefficient maps versus
fractional intracellular volume maps from VERDICT MRI using the PI-QUAL score and
a dedicated Likert scale for artefacts.
Eur J Radiol. 2023;168:111109.
PubMed
Abstract available
Inter-reader variability and reproducibility of the PI-QUAL score in a
multicentre setting.
Eur J Radiol. 2023;168:111091.
PubMed
Abstract available
Administering [(177)Lu]Lu-PSMA-617 Prior to Radical Prostatectomy in Men with
High-risk Localised Prostate Cancer (LuTectomy): A Single-centre, Single-arm,
Phase 1/2 Study.
Eur Urol. 2023 Oct 25:S0302-2838(23)03087-7. doi: 10.1016/j.eururo.2023.
PubMed
Abstract available
Prostate Cancer Mortality Among Elderly Men After Discontinuing Organised
Screening: Long-term Results from the European Randomized Study of Screening for
Prostate Cancer Rotterdam.
Eur Urol. 2023 Oct 31:S0302-2838(23)03207-4. doi: 10.1016/j.eururo.2023.
PubMed
Abstract available
Inhibition of the Cyclin K-CDK12 complex induces DNA damage and increases the
effect of androgen deprivation therapy in prostate cancer.
Int J Cancer. 2023 Nov 2. doi: 10.1002/ijc.34778.
PubMed
Abstract available
Impact of the COVID-19 pandemic on delivery of prostate cancer care in Australia:
An interrupted time series analysis.
Int J Cancer. 2023 Nov 3. doi: 10.1002/ijc.34759.
PubMed
Abstract available
Editorial Comment to Bone-modifying agents are protective for symptomatic
skeletal events in radium-223 treatment.
Int J Urol. 2023;30:1034-1035.
PubMed
Evaluation of sexual function after robot-assisted radical prostatectomy: A
farewell to IIEF questionnaire.
Int J Urol. 2023;30:959-967.
PubMed
Abstract available
Bone-modifying agents are protective for symptomatic skeletal events in
Radium-223 treatment.
Int J Urol. 2023;30:1029-1034.
PubMed
Abstract available
Retrospective evaluation of the improvement in the urinary status-related quality
of life after robot-assisted radical prostatectomy.
Int J Urol. 2023;30:1020-1027.
PubMed
Abstract available
Disparities With Systemic Therapies for Black Men Having Advanced Prostate
Cancer: Where Do We Stand?
J Clin Oncol. 2023 Oct 27:JCO2300949. doi: 10.1200/JCO.23.00949.
PubMed
Abstract available
Racial disparity in the utilization of immunotherapy for advanced prostate
cancer.
J Natl Med Assoc. 2023 Oct 28:S0027-9684(23)00107.
PubMed
Abstract available
Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate
cancer.
Nat Rev Urol. 2023 Oct 31. doi: 10.1038/s41585-023-00827.
PubMed
Abstract available
Cyclosporin A inhibits prostate cancer growth through suppression of E2F8
transcription factor in a MELK?dependent manner.
Oncol Rep. 2023;50:218.
PubMed
Abstract available
Causal inferences and real-world evidence: A comparative effectiveness evaluation
of abiraterone acetate against enzalutamide.
PLoS One. 2023;18:e0293000.
PubMed
Abstract available
Effect of BMI and hemoglobin A1c on survival of veterans with metastatic
castration-resistant prostate cancer treated with abiraterone or enzalutamide.
Prostate. 2023 Nov 1. doi: 10.1002/pros.24644.
PubMed
Abstract available
Inhibition of N-myristoyltransferase activity promotes androgen receptor
degradation in prostate cancer.
Prostate. 2023 Oct 31. doi: 10.1002/pros.24645.
PubMed
Abstract available
Vasectomy and risk of prostate cancer: A Mendelian randomization study and
confounder analysis.
Prostate. 2023 Oct 31. doi: 10.1002/pros.24646.
PubMed
Abstract available
Luteolin induces ferroptosis in prostate cancer cells by promoting TFEB nuclear
translocation and increasing ferritinophagy.
Prostate. 2023 Oct 30. doi: 10.1002/pros.24642.
PubMed
Abstract available
Treatment modalities and survival outcomes in prostate cancer parenchymal brain
metastasis.
Prostate. 2023 Oct 29. doi: 10.1002/pros.24643.
PubMed
Abstract available
Biological role of fructose in the male reproductive system: Potential
implications for prostate cancer.
Prostate. 2023 Oct 27. doi: 10.1002/pros.24631.
PubMed
Abstract available
Nanomechanical-based classification of prostate tumor using atomic force
microscopy.
Prostate. 2023;83:1591-1601.
PubMed
Abstract available
Is prostatic adenocarcinoma with cribriform architecture more difficult to detect
on prostate MRI?
Prostate. 2023;83:1519-1528.
PubMed
Abstract available
The 29th Annual Prostate Cancer Foundation Scientific Retreat Report.
Prostate. 2023 Nov 1:e24640. doi: 10.1002/pros.24640.
PubMed
Abstract available
Urological Tumor: A Narrative Review of Tertiary Lymphatic Structures.
Urol Int. 2023;107:841-847.
PubMed
Abstract available
Thank you for your interest in scientific medicine.